Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Sep. 30, 2025

Equity [Abstract]

Schedule of Accumulated Other Comprehensive (Loss) Income

The activity in AOCI for the three and nine months ended September 30, 2025 and 2024 is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
	(In thousands)
Opening balance - accumulated other comprehensive loss	$	(58,468)	$	(14,313)	$	(27,279)	$	(16,640)
Pension and other postretirement benefits:
Balance at beginning of period, net of tax	$	800	$	279	$	898	$	383
Loss arising during period	(49)		(13)		(147)		(117)
Net loss on pension and other postretirement benefit	(49)		(13)		(147)		(117)
Balance at end of period, net of tax	$	751	$	266	$	751	$	266
Foreign currency:
Balance at beginning of period, net of tax	$	(65,089)	$	(42,792)	$	(46,028)	$	(31,587)
Cumulative translation adjustment	(8,368)		41,282		96,896		3,983
Non-derivative net investment hedges(1)	2,992		(37,262)		(122,107)		(11,168)
Derivative net investment hedge(1)	105		—		(1,493)
Reclassification of derivative net investment hedge to earnings(1)	1,493		—		1,493		—
Reclassification of accumulated CTA on SuperFrio sale proceeds	(1,579)		—		(1,579)		—
Reclassification of CTA to earnings upon sale of partially owned entity	—		—		2,372		—
Net (loss) gain on foreign currency translation	(5,357)		4,020		(24,418)		(7,185)
Balance at end of period, net of tax	$	(70,446)	$	(38,772)	$	(70,446)	$	(38,772)
Designated derivatives:
Balance at beginning of period, net of tax	$	5,821	$	28,200	$	17,851	$	14,564
Cash flow hedge derivatives(1)	437		(22,228)		(13,904)		1,414
Net amount reclassified from AOCI to earnings(1)	(1,367)		(252)		944		(10,258)
Net loss on designated derivatives	(930)		(22,480)		(12,960)		(8,844)
Balance at end of period, net of tax	$	4,891	$	5,720	$	4,891	$	5,720
Closing balance - accumulated other comprehensive loss	$	(64,804)	$	(32,786)	$	(64,804)	$	(32,786)

(1)Refer to Note 5 - Derivative Financial Instruments for details of our derivative and designated non-derivative financial instruments, including the classification on the Condensed Consolidated Statements of Operations for items reclassified from AOCI to Net loss.